Home › Funds › Sofinnova Investments, Inc. › DSGN

Sofinnova Investments, Inc. position in DSGN

DESIGN THERAPEUTICS INC · Health Care

Sofinnova Investments, Inc. reported holding 865,135 shares of DSGN (DESIGN THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$12.5M, representing 0.67% of its reported portfolio and ranking #35 among its reported holdings. Sofinnova Investments, Inc. first reported this position in Q2 2026.

Latest position (Q2 2026)865.13K sh
Reported value held$12.52M
Portfolio Weight0.67%
First reportedQ2 2026
Last changeNew
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Sofinnova Investments, Inc.'s DSGN position evolved

Sofinnova Investments, Inc. first disclosed a stake in DSGN in Q2 2026 at 865,135 shares (US$12.5M).

Quarter by quarter

QuarterSharesValueChange
Q2 2026 865.13K $12.52M New

About DSGN and 13F data

DSGN (DESIGN THERAPEUTICS INC) is a Health Care company. 47 other funds we track also report a position in DSGN — the largest reported positions include SR ONE CAPITAL MANAGEMENT, LP (US$94.4M), Logos Global Management LP (US$43.4M), BAKER BROS. ADVISORS LP (US$38.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding DSGN

All DSGN fund holders →

FAQ

How long has Sofinnova Investments, Inc. held DSGN?

Sofinnova Investments, Inc. has disclosed DSGN holdings in 1 of the last 1 reported quarters, going back to Q2 2026.

What is Sofinnova Investments, Inc.'s current position in DSGN?

As of Q2 2026, Sofinnova Investments, Inc. holds 865.13K shares of DSGN (DESIGN THERAPEUTICS INC), valued at $12.52M, representing 0.67% of its reported portfolio and ranking #35.

Has Sofinnova Investments, Inc. been buying or selling DSGN?

In the latest 13F filing (Q2 2026), Sofinnova Investments, Inc. newly opened its position in DSGN.

Which other funds hold DSGN?

Other major institutional holders of DSGN include SR ONE CAPITAL MANAGEMENT, LP, Logos Global Management LP, BAKER BROS. ADVISORS LP, among 47 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.